Quercetin
- Generic Name
- Quercetin
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C15H10O7
- CAS Number
- 117-39-5
- Unique Ingredient Identifier
- 9IKM0I5T1E
- Background
Quercetin is a flavonol widely distributed in plants. It is an antioxidant, like many other phenolic heterocyclic compounds. Glycosylated forms include RUTIN and quercetrin.
- Associated Conditions
- -
- Associated Therapies
- -
Quercetin Effect on Post-ceserean Pain
- Conditions
- Interventions
- First Posted Date
- 2024-10-21
- Last Posted Date
- 2024-10-21
- Lead Sponsor
- Future University in Egypt
- Target Recruit Count
- 70
- Registration Number
- NCT06650891
Dasatinib Combined With Quercetin to Reverse Chemo Resistance in Triple Negative Breast Cancer
- Conditions
- Interventions
- First Posted Date
- 2024-04-09
- Last Posted Date
- 2024-07-08
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 10
- Registration Number
- NCT06355037
- Locations
- 🇨🇳
270 Dongan Road, Fudan University Shanghai Cancer Center, Shanghai, China
Effect of Quercetin in Treatment of Periodontitis
- Conditions
- Interventions
- First Posted Date
- 2023-07-03
- Last Posted Date
- 2024-01-31
- Lead Sponsor
- Assiut University
- Target Recruit Count
- 20
- Registration Number
- NCT05928546
Safety and Feasibility of Dasatinib and Quercetin in Adults at Risk for Alzheimer's Disease
- First Posted Date
- 2022-06-21
- Last Posted Date
- 2024-03-07
- Lead Sponsor
- Lewis Lipsitz
- Target Recruit Count
- 12
- Registration Number
- NCT05422885
- Locations
- 🇺🇸
Hebrew Senior Life, Boston, Massachusetts, United States
Quercetin in Coronary Artery By-pass Surgery
- Conditions
- Interventions
- First Posted Date
- 2021-05-28
- Last Posted Date
- 2024-03-13
- Lead Sponsor
- Montreal Heart Institute
- Target Recruit Count
- 100
- Registration Number
- NCT04907253
- Locations
- 🇨🇦
Montreal Heart Institute, Montréal, Quebec, Canada
Quercetin In The Treatment Of SARS-COV 2
- Conditions
- Interventions
- First Posted Date
- 2021-04-21
- Last Posted Date
- 2023-07-06
- Lead Sponsor
- Hôpital Universitaire Sahloul
- Target Recruit Count
- 200
- Registration Number
- NCT04853199
- Locations
- 🇹🇳
Riadh Boukef, Sahloul, Sousse, Tunisia
🇹🇳HU Sahloul, sousse, Tunisia, Sousse, Itinéraire Ceinture Cité Sahloul, Tunisia
The Effectiveness of Phytotherapy in SARS-COV2(COVID-19)
- Conditions
- Interventions
- First Posted Date
- 2021-04-20
- Last Posted Date
- 2023-01-04
- Lead Sponsor
- Hôpital Universitaire Sahloul
- Target Recruit Count
- 80
- Registration Number
- NCT04851821
- Locations
- 🇹🇳
Riadh Boukef, Sahloul, Sousse, Tunisia
ALSENLITE: Senolytics for Alzheimer's Disease
- Conditions
- Interventions
- First Posted Date
- 2021-03-05
- Last Posted Date
- 2024-11-25
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 20
- Registration Number
- NCT04785300
- Locations
- 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States
The Study of Quadruple Therapy Zinc, Quercetin, Bromelain and Vitamin C on the Clinical Outcomes of Patients Infected With COVID-19
- Conditions
- Interventions
- First Posted Date
- 2020-07-13
- Last Posted Date
- 2020-07-13
- Lead Sponsor
- Ministry of Health, Saudi Arabia
- Target Recruit Count
- 60
- Registration Number
- NCT04468139
- Locations
- 🇸🇦
Ministry of health.First health cluster ,Riaydh, Riyadh, Saudi Arabia
Targeting Cellular Senescence With Senolytics to Improve Skeletal Health in Older Humans
- First Posted Date
- 2020-03-18
- Last Posted Date
- 2024-07-22
- Lead Sponsor
- Sundeep Khosla, M.D.
- Target Recruit Count
- 74
- Registration Number
- NCT04313634
- Locations
- 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.